Qscription Technologies and Aikenist Technologies have signed a U.S. market-entry framework for Aiken QuickRad, an FDA 510(k) cleared PACS with viewer and 3D viewer.
In short: Qscription Technologies and Aikenist Technologies have signed a framework for bringing Aiken QuickRad, an FDA 510(k) cleared PACS with viewer and 3D viewer, to U.S. radiology providers. Qscription will act as Aikenist's U.S. market-entry consultant, from market assessment and introductions through evaluations, pilots and deployment support.
JACKSON, Wis., November 9, 2026. Qscription Technologies Inc. today announced that it has signed a U.S. market-entry framework with Aikenist Technologies Private Limited of Bengaluru, India, covering Aiken QuickRad.
What the framework covers
Under the framework, Qscription will support Aikenist's U.S. entry for QuickRad. The work includes a U.S. market assessment and go-to-market plan; introductions to U.S. health systems, imaging centers, radiology groups and teleradiology providers; demonstrations, evaluations and pilots; and integration and deployment support with customers' PACS, EHR and IT environments. Specific engagements will be set out in statements of work.
About QuickRad
QuickRad is Aikenist's PACS, with viewer and 3D viewer. It is FDA 510(k) cleared as QuickRad under K242838 (21 CFR 892.2050, product code LLZ).
"QuickRad already holds FDA clearance. Our job is the rest of the path: the right first sites, the integrations U.S. IT teams expect, and evaluations that radiologists trust," said Anurag Velekkatt Sunil Kumar, Project Manager and VP of MedTech at Qscription.
"The United States is a priority market for Aikenist. Working with Qscription gives us a team on the ground that understands how U.S. health systems and radiology groups evaluate and adopt imaging software," said Ashwin Amarapuram, Founder and CEO of Aikenist.
Aikenist at RSNA 2026
Aikenist will exhibit at RSNA 2026 at McCormick Place, Chicago, November 29 to December 3, at Booth 1406.
About Aikenist Technologies
Aikenist Technologies Private Limited, headquartered in Bengaluru, India, develops radiology software spanning PACS and RIS, reporting, MRI acceleration and imaging workflow management for hospitals, diagnostic chains and imaging centers. Learn more at aikenist.com.
About Qscription Technologies
Qscription Technologies is a U.S. market-entry and operations partner for global MedTech and clinical AI companies. Qscription provides market assessment and go-to-market planning, market access and KOL engagement, enterprise integration and U.S. operations support, turning FDA-cleared products into adopted products. Qscription is a Delaware corporation headquartered in Jackson, Wisconsin. Learn more at qscription.tech.
Media contact: Anurag Velekkatt Sunil Kumar, Project Manager and VP of MedTech, +1 715 449 8977, [email protected]
